ISB News

Dr. Sean Gibbons Promoted to Associate Professor

ISB Associate Professor Dr. Sean Gibbons

Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor.

“Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new area of research to ISB and has collaborated with many other labs.”

Since 2021, Gibbons and colleagues have published papers showing the gut microbiome’s role on shaping the human blood metabolome, how the gut microbiome’s composition can predict a patient’s response to statins, how weight loss success or failure can be determined by the genetic capacity of the gut microbiome, and how the gut microbiome can determine healthy vs. unhealthy aging trajectories. His research has been covered by a variety of news outlets, including a feature article in The New York Times

In this ISB-Seattle Science Foundation video, Dr. Sean Gibbons discusses the human microbiome, how it affects our health, how it changes the way we look at health care, and more.

In the wake of the pandemic lockdown, Gibbons also spearheaded an annual virtual microbiome course and symposium series. This free series has been incredibly successful. Over the past three years, more than 4,000 registrants from more than 80 countries have participated. Videos of the 2022 three-day program can be viewed here.

In 2022, Gibbons secured a large R01 grant from the National Institutes of Health, was recognized on Clarivate’s Highly Cited Researchers list as among the top 1 percent of the world’s most cited researchers, and was honored as a Health Care Leadership Awardee by the Puget Sound Business Journal.  

“This promotion to Associate Professor is incredibly gratifying,” Gibbons said. “I have the great fortune of working alongside incredible scientists in a field that is yielding important, actionable findings at breakneck pace. And none of this would be possible without my incredible research team, whose passion and curiosity keep us at the leading edge of our field. I look forward to many more years of research at ISB.”

Prior to joining ISB, Gibbons completed his postdoc training in the Department of Biological Engineering at MIT, and he received his PhD in biophysical sciences from the University of Chicago. 

You can keep up with Gibbons on Twitter and on the Gibbons Lab website.

In this video, Drs. Sean Gibbons, left, and Christian Diener discuss their research showing which blood metabolites are associated with the gut microbiome, genetics, or the interplay between both, and why these findings are significant. 

Recent Articles

  • Drs. Jennifer Hadlock and Alexandra Ralevski

    ISB Study Highlights AI’s Potential and Pitfalls in Analyzing Health Data

    New peer-reviewed research out of ISB highlights the strengths of large language models in uncovering social determinants of health while underscoring the need for human oversight and improved de-identification methods.

  • Dr. Sid Venkatesh

    Sid Venkatesh Publishes Co-First Authored Paper in Science

    ISB Assistant Professor Dr. Sid Venkatesh is the co-first author of a paper in the journal Science. While at Washington University in St. Louis, Venkatesh and colleagues identified a novel gut microbial enzyme that impacts satiety-related signaling pathways in undernourished children treated with microbiota-directed complementary foods.

  • AmeriCorps Member Faduma Hussein Joins ISB as Public Health Ambassador Coordinator

    Faduma Hussein recently joined the ISB Education team as the Public Health Ambassador Coordinator, becoming only the fourth AmeriCorps member to serve at ISB. In this Q&A, she shares insights into her education, what drew her to ISB, career aspirations, and more.